Dr. Amir Iravani, MD
Claim this profileWashington University School of Medicine at Barnes-Jewish Hospital
Studies Prostate Cancer
Studies Skin Cancer
3 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Amir Iravani, MD is currently running
RYZ101
for Neuroendocrine Tumors
This trial tests RYZ101, a new drug, in patients with advanced GEP-NETs that haven't responded to previous treatments. The drug aims to target specific receptors on the tumor cells to stop their growth.
Recruiting2 awards Phase 312 criteria
Cu-SAR-bisPSMA
for Prostate Cancer
This trial is testing a new radioactive treatment called 67Cu-SAR-bisPSMA in patients with advanced prostate cancer that has spread and does not respond to hormone treatments. The treatment works by sticking to cancer cells and using radioactivity to destroy them.
Recruiting1 award Phase 1 & 224 criteria
More about Amir Iravani, MD
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Amir Iravani, MD has experience with
- Lutetium Lu 177-PSMA-617
- 64Cu-SAR-bisPSMA
- 67Cu-SAR-bisPSMA
- RYZ101
Breakdown of trials Amir Iravani, MD has run
Skin Cancer
Pancreatic Cancer
Small Intestinal Neoplasms
Uterine Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amir Iravani, MD specialize in?
Amir Iravani, MD focuses on Prostate Cancer and Skin Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Amir Iravani, MD currently recruiting for clinical trials?
Yes, Amir Iravani, MD is currently recruiting for 3 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Amir Iravani, MD has studied deeply?
Yes, Amir Iravani, MD has studied treatments such as Lutetium Lu 177-PSMA-617, 64Cu-SAR-bisPSMA, 67Cu-SAR-bisPSMA.
What is the best way to schedule an appointment with Amir Iravani, MD?
Apply for one of the trials that Amir Iravani, MD is conducting.
What is the office address of Amir Iravani, MD?
The office of Amir Iravani, MD is located at: Washington University School of Medicine at Barnes-Jewish Hospital, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine at Barnes-Jewish Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.